Combined treatment method for type 2 diabetes by using camel milk and rosiglitazone maleate

Abstract

The invention is to use camel milk and rosiglitazone maleate for combined treatment of type II diabetes, and relates to the field of medicine. It was reported that camel milk can reduce trypsin dosage for patients with type I diabetes mellitus. But there is no report about the effect of camel milk on type II diabetes. The experiment of the invention indicates that drinking camel milk alone has the same effect with rosiglitazone maleate in reducing blood sugar, blood lipid, and trypsin. Combined drinking of rosiglitazone maleate 4mg and camel milk 8ml once each day has better therapeutic effect than exclusive use of rosiglitazone maleate in reducing blood sugar, blood lipid, and trypsin. The invention has the advantages of convenient administration and low cost, and also is benefit for the economical development of pastoral zone.

Description

technical field [0001] The invention relates to the field of medicine, especially medicine for treating diabetes. Background technique [0002] Diabetes is a systemic chronic metabolic disease. It is mainly due to the absolute or relative deficiency of insulin in the body, which leads to the metabolic disorder of sugar, fat and protein. Studies have now confirmed that the main pathophysiological basis of type II diabetes is insulin resistance, that is, the body's normal response to insulin is reduced, resulting in blood insulin levels much higher than normal, which is caused by the disorder of lipid metabolism in the patient's body . Therefore, the current treatment of type II diabetes is mainly to regulate lipid metabolism, rather than simply lowering blood sugar. [0003] In today's world, with the development of economy and the prolongation of human life span, the number of diabetic patients is increasing day by day. At present, the prevalence rate in developed countri...

AI Technical Summary

Problems solved by technology

[0004] It has been reported that the use of camel milk in type 1 diabetes patients can reduce the amount of insulin in patients, but there is no experimental study of camel milk on type 2 diabetes

In addition, various hypoglycemic drugs currently used clinically have contraindications and adverse reactions to varying degrees, and long-term use can also cause secondary failure; even with insulin injections, lipoatrophy, hypertrophy, and blurred vision at the injection site may occur side effects, which makes them very limited in clinical application